Citius Oncology, Inc. CTOR Outstanding Remaining Balance Of Milestone
Outstanding Remaining Balance Of Milestone at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept ctor:OutstandingRemainingBalanceOfMilestone.
The official record: Citius Oncology, Inc.’s 10-Q, filed February 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s outstanding remaining balance of milestone.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s outstanding remaining balance of milestone?
- Citius Oncology, Inc. (CTOR) reported outstanding remaining balance of milestone of $18.25M in Q4 2025.
- How has Citius Oncology, Inc.'s outstanding remaining balance of milestone changed year-over-year?
- Citius Oncology, Inc.'s outstanding remaining balance of milestone increased by 269.6% year-over-year, from $4.94M to $18.25M.
- What does outstanding remaining balance of milestone mean?
- Indicates the total undiscounted value of future contingent payments that the company is obligated to pay if specific development or commercial milestones are met. This provides visibility into the company's long-term off-balance-sheet liabilities related to its licensing and acquisition agreements. It is essential for assessing the company's future cash flow requirements.